Related Experiment Videos
Delayed hypersensitivity to scopolamine delivered by a transdermal device.
Journal of the American Academy of Dermatology
|August 1, 1985
Summary
Transdermal scopolamine patches can cause delayed hypersensitivity reactions. Patch testing identified the scopolamine molecule as the likely antigen, highlighting a potential concern for dermatologists.
Area of Science:
- Pharmacology
- Dermatology
- Immunology
Background:
- Transdermal drug delivery systems offer a convenient route for systemic medication administration.
- Transderm-Scop, a transdermal device utilizing scopolamine, is commercially available.
Observation:
- Delayed hypersensitivity reactions were observed in patients using Transderm-Scop.
- Patch testing was conducted using scopolamine and structurally related alkaloids.
Findings:
- The study confirms delayed hypersensitivity to scopolamine, the active component in Transderm-Scop.
- Patch testing suggests that a specific site on the scopolamine molecule is responsible for the allergic reaction.
Implications:
- Understanding the antigenic properties of scopolamine is crucial for managing transdermal drug delivery.
- Dermatologists need to be aware of these hypersensitivity reactions as transdermal technology expands.
- Further research into the mechanism of transdermal drug delivery and potential adverse reactions is warranted.